J. Allen McCutchan, MD, MSc
J. Allen McCutchan, MD, MSc is co-Founder and Associate Program Director of the MAS-Clinical Research (MAS-CR) program, and Professor of Medicine, Emeritus, Internal Medicine in the Division of Infectious Diseases, UC San Diego. He graduated from Yale University Medical School in 1968, was an intern and resident at Vanderbilt University, served his senior residency in Internal Medicine at Yale-New Haven Hospital, and completed Infectious Diseases Postdoctoral training as a Fellow in Infectious Diseases at UCSD. He was awarded a Milbank Fund Scholarship to attend a Masters of Science in Epidemiology course at the London School of Hygiene and Tropical Medicine, University of London. He served on the Infectious Diseases faculty of the UCSD School of Medicine from 1976 until he semiretired in 2009, He has authored or coauthored over 330 peer-reviewed research papers in topics such as HIV, other infectious diseases, neurology, and the neuropathogenesis of HIV. He also directs the UCSD Military International HIV Training Program, sponsored by the US Department of Defense, that trains military medical physicians and other personnel from over 60 countries in managing HIV and (more recently) COVID-19.
- Directed, converted to on-line teaching, and lectured in two core courses in the MAS-CR curriculum: 1) interventional research (clinical trials) and 2) regulation and ethics of clinical research
- Mentored 8 MAS-CR students in their ISP projects
- Provided lectures on topics such as study design and the role of chronic inflammation in brain damage to young investigators in the field of NeuroAIDS
- Provided online lectures on COVID to over 200 military medical physicians in 24 African countries under a grant from the US Department of Defense
- Published 15 peer-reviewed articles on topics such as the effects of chronic infections and systemic inflammation on HIV-associated cognitive impairment
- Designing clinical trial of cannabidiol (CBD) for treatment of anxiety, depression, and cognitive impairment in patients recovering from COVID